Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

CD56dimCD16+ NK cells downregulate CD16 following target cell induced activation of matrix metalloproteinases

Leukemia volume 21, pages 356–359 (2007)Cite this article

Natural killer (NK) cells are immune effector cells that recognize both virally infected and malignant target cells. Unlike T and B cells, NK cells do not belong to the adaptive immune system, and their activation and cytotoxicity is regulated via a series of non-rearranged cell surface receptors. These receptors transmit either activating or inhibitory signals, the summation of which is thought to dictate whether NK cell activation occurs or not. Functionally NK cells are able to kill target cells without prior sensitization and release potent pro-inflammatory cytokines such as interferon (IFN) and tumor necrosis factor (TNF). Discrete NK cell subsets can be identified in peripheral blood on the basis of CD56 and CD16 staining (reviewed by Cooper et al.1). CD56brightCD16−/+ cells are more potent producers of IFN-γ in response to monokine stimulation and reciprocally interact with dendritic cells, leading to the activation of both cell types, whereas CD56dimCD16+ NK cells show higher cytotoxicity against malignant targets. By definition, NK cells lack the expression of CD3 and the T-cell receptor. CD3+CD56+ cells are present in the peripheral blood (PB) and as these cells belong to the T-cell lineage, they share phenotypic and functional properties with NK cells.2 When studying NK cells the interference of these NK-like T cells should be excluded.

One of the main mechanisms of target cell killing is through the granule release pathway. Following target cell conjugation and NK activation, cytotoxic granules move toward the cell surface, fuse with the cell membrane and the granule contents (including perforin and granzymes) are expelled into the synaptic junction between the effector and target cells. Until recently, it has not been possible to identify individual effector cells that have extruded their granule contents. However, recent studies show that specific membrane proteins, such as CD107a (lysosome-associated membrane protein 1, LAMP-1) are located within the cytotoxic granule membrane and are transiently expressed on the cell surface following degranulation. Monoclonal antibody (mAb) against CD107a identifies cells that have recently released their granule contents.3

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

References

  1. Cooper MA, Fehniger TA, Caligiuri MA . The biology of human natural killer-cell subsets. Trends Immunol 2001; 22: 633–640.

    Article  CAS  Google Scholar 

  2. Lu PH, Negrin RS . A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency. J Immunol 1994; 153: 1687–1696.

    CAS  PubMed  Google Scholar 

  3. Rubio V, Stuge TB, Singh N, Betts MR, Weber JS, Roederer M et al. Ex vivo identification, isolation and analysis of tumor-cytolytic T cells. Nat Med 2003; 9: 1377–1382.

    Article  CAS  Google Scholar 

  4. Penack O, Gentilini C, Fischer L, Asemissen AM, Scheibenbogen C, Thiel E et al. CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets. Leukemia 2005; 19: 835–840.

    Article  CAS  Google Scholar 

  5. Zimmer J, Andres E, Hentges F . NK cell subsets and CD107a mobilization assay. Leukemia 2005; 19: 1849–1851; author reply 1857.

    Article  CAS  Google Scholar 

  6. Harrison D, Phillips JH, Lanier LL . Involvement of a metalloprotease in spontaneous and phorbol ester-induced release of natural killer cell-associated Fc gamma RIII (CD16-II). J Immunol 1991; 147: 3459–3465.

    CAS  PubMed  Google Scholar 

  7. Borrego F, Lopez-Beltran A, Pena J, Solana R . Downregulation of Fc gamma receptor IIIA alpha (CD16-II) on natural killer cells induced by anti-CD16 mAb is independent of protein tyrosine kinases and protein kinase C. Cell Immunol 1994; 158: 208–217.

    Article  CAS  Google Scholar 

  8. Nagler A, Lanier LL, Cwirla S, Phillips JH . Comparative studies of human FcRIII-positive and negative natural killer cells. J Immunol 1989; 143: 3183–3191.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA

    B Grzywacz, N Kataria & M R Verneris

Authors
  1. B Grzywacz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N Kataria
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M R Verneris
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M R Verneris.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grzywacz, B., Kataria, N. & Verneris, M. CD56dimCD16+ NK cells downregulate CD16 following target cell induced activation of matrix metalloproteinases. Leukemia 21, 356–359 (2007). https://doi.org/10.1038/sj.leu.2404499

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404499

This article is cited by

Search

Advanced search

Quick links